COVID-19 BiPAP device bridging option for ventilator shortage
Syneos Health Medical Director and critical care pulmonologist Dr. Keith Robinson discusses the Ventilator Initiative that is to raise awareness among healthcare providers of a bridging option, using intubated Bi-level Positive Airway Pressure (BiPAP) devices for appropriate COVID-19 patients. This is to address the predicted ventilator shortage. The open-access platform www.COVID-BiPAPinfo.com is now live and provides physicians with practical steps and training materials for use of BiPAP with intubated COVID-19 patients suffering respiratory failure.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on COVID. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in COVID and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about COVID?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Keith Robinson is Medical Director with the Medical Management & Scientific Services group of Syneos Health. Keith is a board-certified Pulmonary Medicine and Critical Care Medicine physician with over 14 years of clinical experience. Before Syneos, Keith worked as an Intensivist and Pulmonary Medicine Consultant with Pulmonary Physicians of South Florida, LLC, serving as Medical Director of Fusion Health Pulmonary Rehabilitation & Wellness for 7 years. His professional activities include 10 years of clinical research, as a principle investigator, in pneumonia, asthma, COPD, and pulmonary hypertension trials. In addition, Keith has spent 10 years as a consultant and advisor to Astra Zeneca, Mylan, Theravance, Sunovion, Actelion, and CAIRE Industries.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
